Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Molecular & Cellular Oncology|June 18, 2016
Taking out the JNK: A window of opportunity to improve cancer therapyPetranel T FerraoLeukemia Research|March 22, 2003
Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liverPetranel T Ferrao, Thomas J Gonda, Leonie K AshmanMolecular Cancer Therapeutics|December 17, 2002
Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistantMichelle J Frost, Petranel T Ferrao, Timothy P Hughes, et al.Blood|July 26, 2003
Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitroPetranel T Ferrao, Michelle J Frost, Shoo-Peng Siah, et al.Frontiers in Oncology|March 13, 2015
Phenotype switching in melanoma: implications for progression and therapyFrederic Zhentao Li, Amardeep Singh Dhillon, Robin L Anderson, et al.Science Signaling|August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanomaRachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.Pageof 1